AGIO
NASDAQ · Biotechnology
Agios Pharmaceuticals Inc
$33.54
+0.47 (+1.42%)
Open$33.30
Previous Close$33.07
Day High$33.82
Day Low$33.30
52W High$46.00
52W Low$22.24
Volume—
Avg Volume788.0K
Market Cap2.00B
P/E Ratio—
EPS$-7.01
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-67.6% upside
Current
$33.54
$33.54
Target
$10.87
$10.87
$8.41
$10.87 avg
$14.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 56.00M | 35.91M | 198.27M |
| Net Income | -427,851,722 | -246,885,009 | -11,344,752 |
| Profit Margin | -764.0% | -725.8% | -5.7% |
| EBITDA | -483,998,097 | -294,799,123 | -15,767,673 |
| Free Cash Flow | — | — | -7,306,109 |
| Rev Growth | +56.0% | +56.0% | -2.9% |
| Debt/Equity | — | — | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |